CEI Ventures — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Galatea Biogalatea.bioAug 2024 · $25M

Genomics company building a multi-ancestry biobank and AI-driven analytics for clinical genetic testing and drug discovery.

HealthtechMiami Lakes, US

Carlos D. Bustamante(Executive Officer, Director)inArthur Polk(Executive Officer)Alexander Ioannidis(Director)

Board Wale Ayeni(Director)inMohit Kaushal(Director)Nicholas Katsanis(Director)

Co-investorsCitta Capital F-Prime Capital Founder Collective Function Ventures Helios Digital Ventures LifeX Ventures +4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.